{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T19:35:46Z","timestamp":1793043346453,"version":"4.5.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,12,17]],"date-time":"2021-12-17T00:00:00Z","timestamp":1639699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,12,17]],"date-time":"2021-12-17T00:00:00Z","timestamp":1639699200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Acute-on-chronic liver failure (ACLF) is characterized predominantly by non-apoptotic forms of hepatocyte cell death. Necroptosis is a form of programmed lytic cell death in which receptor interacting protein kinase (RIPK) 1, RIPK3 and phosphorylated mixed lineage kinase domain-like (pMLKL) are key components. This study was performed to determine the role of RIPK1 mediated cell death in ACLF. RIPK3 plasma levels and hepatic expression of RIPK1, RIPK3, and pMLKL were measured in healthy volunteers, stable patients with cirrhosis, and in hospitalized cirrhotic patients with acutely decompensated cirrhosis, with and without ACLF (AD). The role of necroptosis in ACLF was studied in two animal models of ACLF using inhibitors of RIPK1, necrostatin-1 (NEC-1) and SML2100 (RIPA56). Plasma RIPK3 levels predicted the risk of 28- and 90-day mortality (AUROC, 0.653 (95%CI 0.530\u20130.776), 0.696 (95%CI 0.593\u20130.799)] and also the progression of patients from no ACLF to ACLF [0.744 (95%CI 0.593\u20130.895)] and the results were validated in a 2<jats:sup>nd<\/jats:sup> patient cohort. This pattern was replicated in a rodent model of ACLF that was induced by administration of lipopolysaccharide (LPS) to bile-duct ligated rats and carbon tetrachloride-induced fibrosis mice administered galactosamine (CCL<jats:sub>4<\/jats:sub>\/GalN). Suppression of caspase-8 activity in ACLF rodent model was observed suggesting a switch from caspase-dependent cell death to necroptosis. NEC-1 treatment prior to administration of LPS significantly reduced the severity of ACLF manifested by reduced liver, kidney, and brain injury mirrored by reduced hepatic and renal cell death. Similar hepato-protective effects were observed with RIPA56 in a murine model of ACLF induced by CCL<jats:sub>4<\/jats:sub>\/GalN. These data demonstrate for the first time the importance of RIPK1 mediated cell death in human and rodent ACLF. Inhibition of RIPK1 is a potential novel therapeutic approach to prevent progression of susceptible patients from no ACLF to ACLF.<\/jats:p>","DOI":"10.1038\/s41419-021-04442-9","type":"journal-article","created":{"date-parts":[[2021,12,17]],"date-time":"2021-12-17T13:03:34Z","timestamp":1639746214000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["The role of RIPK1 mediated cell death in acute on chronic liver failure"],"prefix":"10.1038","volume":"13","author":[{"given":"Takayuki","family":"Kondo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stewart","family":"Macdonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelius","family":"Engelmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abeba","family":"Habtesion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Macnaughtan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gautam","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajeshwar P.","family":"Mookerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Pavesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Moreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Angeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicente","family":"Arroyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fausto","family":"Andreola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7747-4015","authenticated-orcid":false,"given":"Rajiv","family":"Jalan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,12,17]]},"reference":[{"key":"4442_CR1","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1159\/000047017","volume":"20","author":"R Jalan","year":"2002","unstructured":"Jalan R, Williams R. Acute-on-chronic liver failure: pathophysiological basis of therapeutic options. Blood Purif. 2002;20:252\u201361. https:\/\/doi.org\/10.1159\/000047017","journal-title":"Blood Purif"},{"key":"4442_CR2","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1016\/j.jhep.2012.06.026","volume":"57","author":"R Jalan","year":"2012","unstructured":"Jalan R, Gines P, Olson JC, Mookerjee RP, Moreau R, Garcia-Tsao G, et al. Acute-on chronic liver failure. J Hepatol. 2012;57:1336\u201348. https:\/\/doi.org\/10.1016\/j.jhep.2012.06.026","journal-title":"J Hepatol"},{"key":"4442_CR3","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1016\/j.jhep.2015.07.004","volume":"63","author":"M Bernardi","year":"2015","unstructured":"Bernardi M, Moreau R, Angeli P, Schnabl B, Arroyo V. Mechanisms of decompensation and organ failure in cirrhosis: From peripheral arterial vasodilation to systemic inflammation hypothesis. J Hepatol. 2015;63:1272\u201384. https:\/\/doi.org\/10.1016\/j.jhep.2015.07.004","journal-title":"J Hepatol"},{"key":"4442_CR4","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1055\/s-0036-1583199","volume":"36","author":"R Moreau","year":"2016","unstructured":"Moreau R. The pathogenesis of ACLF: the inflammatory response and immune function. Semin Liver Dis. 2016;36:133\u201340. https:\/\/doi.org\/10.1055\/s-0036-1583199","journal-title":"Semin Liver Dis"},{"key":"4442_CR5","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1002\/hep.28740","volume":"64","author":"J Cl\u00e0ria","year":"2016","unstructured":"Cl\u00e0ria J, Stauber RE, Coenraad MJ, Moreau R, Jalan R, Pavesi M, et al. Systemic inflammation in decompensated cirrhosis: characterization and role in acute-on-chronic liver failure. Hepatology. 2016;64:1249\u201364. https:\/\/doi.org\/10.1002\/hep.28740","journal-title":"Hepatology"},{"key":"4442_CR6","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1053\/j.gastro.2013.02.042","volume":"144","author":"R Moreau","year":"2013","unstructured":"Moreau R, Jalan R, Gines P, Pavesi M, Angeli P, Cordoba J, et al. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology. 2013;144:1426\u201337. https:\/\/doi.org\/10.1053\/j.gastro.2013.02.042. 1437 e1421-1429","journal-title":"Gastroenterology"},{"key":"4442_CR7","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.jhep.2014.12.029","volume":"62","author":"P Angeli","year":"2015","unstructured":"Angeli P, Gin\u00e8s P, Wong F, Bernardi M, Boyer TD, Gerbes A, et al. Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites. J Hepatol. 2015;62:968\u201374. https:\/\/doi.org\/10.1016\/j.jhep.2014.12.029","journal-title":"J Hepatol"},{"key":"4442_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/cc11882","volume":"16","author":"R Jalan","year":"2012","unstructured":"Jalan R, Stadlbauer V, Sen S, Cheshire L, Chang YM, Mookerjee RP. Role of predisposition, injury, response and organ failure in the prognosis of patients with acute-on-chronic liver failure: a prospective cohort study. Crit Care. 2012;16:R227 https:\/\/doi.org\/10.1186\/cc11882","journal-title":"Crit Care"},{"key":"4442_CR9","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1002\/hep.29581","volume":"67","author":"S Macdonald","year":"2018","unstructured":"Macdonald S, Andreola F, Bachtiger P, Amoros A, Pavesi M, Mookerjee R, et al. Cell death markers in patients with cirrhosis and acute decompensation. Hepatology. 2018;67:989\u20131002. https:\/\/doi.org\/10.1002\/hep.29581","journal-title":"Hepatology"},{"key":"4442_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-57284-z","volume":"10","author":"C Engelmann","year":"2020","unstructured":"Engelmann C, Adebayo D, Oria M, De Chiara F, Novelli S, Habtesion A, et al. Recombinant alkaline phosphatase prevents acute on chronic liver failure. Sci Rep. 2020;10:389 https:\/\/doi.org\/10.1038\/s41598-019-57284-z","journal-title":"Sci Rep"},{"key":"4442_CR11","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jhep.2020.01.011","volume":"73","author":"C Engelmann","year":"2020","unstructured":"Engelmann C, Sheikh M, Sharma S, Kondo T, Loeffler-Wirth H, Zheng YB, et al. Toll-like receptor 4 is a therapeutic target for prevention and treatment of liver failure. J Hepatol. 2020;73:102\u201312.","journal-title":"J Hepatol"},{"key":"4442_CR12","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1016\/j.jhep.2021.01.002","volume":"75","author":"C Engelmann","year":"2021","unstructured":"Engelmann C, Claria J, Szabo G, Bosch J, Bernardi M. Pathophysiology of decompensated cirrhosis: portal hypertension, circulatory dysfunction, inflammation, metabolism and mitochondrial dysfunction. J Hepatol. 2021;75:S49\u2013S66. https:\/\/doi.org\/10.1016\/j.jhep.2021.01.002. Suppl 1","journal-title":"J Hepatol"},{"key":"4442_CR13","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.immuni.2013.02.003","volume":"38","author":"A Kaczmarek","year":"2013","unstructured":"Kaczmarek A, Vandenabeele P, Krysko DV. Necroptosis: the release of damage-associated molecular patterns and its physiological relevance. Immunity. 2013;38:209\u201323. https:\/\/doi.org\/10.1016\/j.immuni.2013.02.003","journal-title":"Immunity"},{"key":"4442_CR14","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.jhep.2019.11.008","volume":"72","author":"A Majdi","year":"2020","unstructured":"Majdi A, Aoudjehane L, Ratziu V, Islam T, Afonso MB, Conti F, et al. Inhibition of receptor-interacting protein kinase 1 improves experimental non-alcoholic fatty liver disease. J Hepatol. 2020;72:627\u201335. https:\/\/doi.org\/10.1016\/j.jhep.2019.11.008","journal-title":"J Hepatol"},{"key":"4442_CR15","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.immuni.2012.09.015","volume":"38","author":"TB Kang","year":"2013","unstructured":"Kang TB, Yang SH, Toth B, Kovalenko A, Wallach D. Caspase-8 blocks kinase RIPK3-mediated activation of the NLRP3 inflammasome. Immunity. 2013;38:27\u201340. https:\/\/doi.org\/10.1016\/j.immuni.2012.09.015","journal-title":"Immunity"},{"key":"4442_CR16","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1002\/hep.28676","volume":"64","author":"S Roychowdhury","year":"2016","unstructured":"Roychowdhury S, McCullough RL, Sanz-Garcia C, Saikia P, Alkhouri N, Matloob A, et al. Receptor interacting protein 3 protects mice from high-fat diet-induced liver injury. Hepatology. 2016;64:1518\u201333. https:\/\/doi.org\/10.1002\/hep.28676","journal-title":"Hepatology"},{"key":"4442_CR17","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.critrevonc.2011.08.004","volume":"82","author":"W Wu","year":"2012","unstructured":"Wu W, Liu P, Li J. Necroptosis: an emerging form of programmed cell death. Crit Rev Oncol Hematol. 2012;82:249\u201358. https:\/\/doi.org\/10.1016\/j.critrevonc.2011.08.004","journal-title":"Crit Rev Oncol Hematol"},{"key":"4442_CR18","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1126\/science.1172308","volume":"325","author":"DW Zhang","year":"2009","unstructured":"Zhang DW, Shao J, Lin J, Zhang N, Lu BJ, Lin SC, et al. RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis. Science. 2009;325:332\u20136. https:\/\/doi.org\/10.1126\/science.1172308","journal-title":"Science"},{"key":"4442_CR19","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1056\/NEJMra1310050","volume":"370","author":"A Linkermann","year":"2014","unstructured":"Linkermann A, Green DR. Necroptosis. N. Engl J Med. 2014;370:455\u201365. https:\/\/doi.org\/10.1056\/NEJMra1310050","journal-title":"N. Engl J Med"},{"key":"4442_CR20","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/ni.3206","volume":"16","author":"J Silke","year":"2015","unstructured":"Silke J, Rickard JA, Gerlic M. The diverse role of RIP kinases in necroptosis and inflammation. Nat Immunol. 2015;16:689\u201397. https:\/\/doi.org\/10.1038\/ni.3206","journal-title":"Nat Immunol"},{"key":"4442_CR21","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.molcel.2014.03.003","volume":"54","author":"H Wang","year":"2014","unstructured":"Wang H, Sun L, Su L, Rizo J, Liu L, Wang LF, et al. Mixed lineage kinase domain-like protein MLKL causes necrotic membrane disruption upon phosphorylation by RIP3. Mol Cell. 2014;54:133\u201346. https:\/\/doi.org\/10.1016\/j.molcel.2014.03.003","journal-title":"Mol Cell"},{"key":"4442_CR22","doi-asserted-by":"publisher","first-page":"16089","DOI":"10.1038\/cddiscovery.2016.89","volume":"2","author":"L Dara","year":"2016","unstructured":"Dara L, Liu ZX, Kaplowitz N. Questions and controversies: the role of necroptosis in liver disease. Cell Death Disco. 2016;2:16089 https:\/\/doi.org\/10.1038\/cddiscovery.2016.89","journal-title":"Cell Death Disco"},{"key":"4442_CR23","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1002\/hep.26547","volume":"58","author":"A Ramachandran","year":"2013","unstructured":"Ramachandran A, McGill MR, Xie Y, Ni HM, Ding WX, Jaeschke H. Receptor interacting protein kinase 3 is a critical early mediator of acetaminophen-induced hepatocyte necrosis in mice. Hepatology. 2013;58:2099\u2013108. https:\/\/doi.org\/10.1002\/hep.26547","journal-title":"Hepatology"},{"key":"4442_CR24","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1002\/hep.26200","volume":"57","author":"S Roychowdhury","year":"2013","unstructured":"Roychowdhury S, McMullen MR, Pisano SG, Liu X, Nagy LE. Absence of receptor interacting protein kinase 3 prevents ethanol-induced liver injury. Hepatology. 2013;57:1773\u201383. https:\/\/doi.org\/10.1002\/hep.26200","journal-title":"Hepatology"},{"key":"4442_CR25","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1042\/CS20140732","volume":"129","author":"MB Afonso","year":"2015","unstructured":"Afonso MB, Rodrigues PM, Carvalho T, Caridade M, Borralho P, Cortez-Pinto H, et al. Necroptosis is a key pathogenic event in human and experimental murine models of non-alcoholic steatohepatitis. Clin Sci (Lond). 2015;129:721\u201339.","journal-title":"Clin Sci (Lond)"},{"key":"4442_CR26","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1021\/acs.jmedchem.6b01196","volume":"60","author":"Y Ren","year":"2017","unstructured":"Ren Y, Su Y, Sun L, He S, Meng L, Liao D, et al. Discovery of a highly potent, selective, and metabolically stable inhibitor of Receptor-Interacting Protein 1 (RIP1) for the treatment of systemic inflammatory response syndrome. J Med Chem. 2017;60:972\u201386.","journal-title":"J Med Chem"},{"key":"4442_CR27","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1002\/hep.510300515","volume":"30","author":"D Harry","year":"1999","unstructured":"Harry D, Anand R, Holt S, Davies S, Marley R, Fernando B, et al. Increased sensitivity to endotoxemia in the bile duct-ligated cirrhotic rat. Hepatology. 1999;30:1198\u2013205.","journal-title":"Hepatology"},{"key":"4442_CR28","doi-asserted-by":"publisher","first-page":"48434","DOI":"10.1074\/jbc.M407190200","volume":"279","author":"D Liu","year":"2004","unstructured":"Liu D, Li C, Chen Y, Burnett C, Liu XY, Downs S, et al. Nuclear import of proinflammatory transcription factors is required for massive liver apoptosis induced by bacterial lipopolysaccharide. J Biol Chem. 2004;279:48434\u201342.","journal-title":"J Biol Chem"},{"key":"4442_CR29","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nmeth.2089","volume":"9","author":"CA Schneider","year":"2012","unstructured":"Schneider CA, Rasband WS, Eliceiri KW. NIH image to ImageJ: 25 years of image analysis. Nat Methods. 2012;9:671\u20135. https:\/\/doi.org\/10.1038\/nmeth.2089","journal-title":"Nat Methods"},{"key":"4442_CR30","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, et al. Fiji: an open-source platform for biological-image analysis. Nat Methods. 2012;9:676\u201382. https:\/\/doi.org\/10.1038\/nmeth.2019","journal-title":"Nat Methods"},{"key":"4442_CR31","doi-asserted-by":"publisher","first-page":"3755","DOI":"10.4049\/jimmunol.1600818","volume":"197","author":"J Claria","year":"2016","unstructured":"Claria J, Arroyo V, Moreau R. The acute-on-chronic liver failure syndrome, or when the innate immune system goes astray. J Immunol. 2016;197:3755\u201361. https:\/\/doi.org\/10.4049\/jimmunol.1600818","journal-title":"J Immunol"},{"key":"4442_CR32","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1016\/j.jhep.2013.01.023","volume":"58","author":"V Balasubramaniyan","year":"2013","unstructured":"Balasubramaniyan V, Kumar Dhar D, Warner AE, Li W-YV, Amiri AF, Bright B, et al. Importance of Connexin-43 based gap junction in cirrhosis and acute-on-chronic liver failure. J Hepatol. 2013;58:1194\u20131200. https:\/\/doi.org\/10.1016\/j.jhep.2013.01.023","journal-title":"J Hepatol"},{"key":"4442_CR33","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.apsb.2016.09.003","volume":"7","author":"F Li","year":"2017","unstructured":"Li F, Miao L, Sun H, Zhang Y, Bao X, Zhang D. Establishment of a new acute-on-chronic liver failure model. Acta Pharm Sin B. 2017;7:326\u201333. https:\/\/doi.org\/10.1016\/j.apsb.2016.09.003","journal-title":"Acta Pharm Sin B"},{"key":"4442_CR34","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.ceb.2009.12.003","volume":"22","author":"DE Christofferson","year":"2010","unstructured":"Christofferson DE, Yuan J. Necroptosis as an alternative form of programmed cell death. Curr Opin Cell Biol. 2010;22:263\u20138. https:\/\/doi.org\/10.1016\/j.ceb.2009.12.003","journal-title":"Curr Opin Cell Biol"},{"key":"4442_CR35","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1007\/s10495-017-1358-2","volume":"22","author":"S Chen","year":"2017","unstructured":"Chen S, Lv X, Hu B, Shao Z, Wang B, Ma K, et al. RIPK1\/RIPK3\/MLKL-mediated necroptosis contributes to compression-induced rat nucleus pulposus cells death. Apoptosis. 2017;22:626\u201338. https:\/\/doi.org\/10.1007\/s10495-017-1358-2","journal-title":"Apoptosis"},{"key":"4442_CR36","doi-asserted-by":"publisher","first-page":"e72904","DOI":"10.1371\/journal.pone.0072904","volume":"8","author":"A Aravinthan","year":"2013","unstructured":"Aravinthan A, Pietrosi G, Hoare M, Jupp J, Marshall A, Verrill C, et al. Hepatocyte expression of the senescence marker p21 is linked to fibrosis and an adverse liver-related outcome in alcohol-related liver disease. PLoS ONE. 2013;8:e72904 https:\/\/doi.org\/10.1371\/journal.pone.0072904","journal-title":"PLoS ONE"},{"key":"4442_CR37","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.jhep.2012.10.031","volume":"58","author":"A Aravinthan","year":"2013","unstructured":"Aravinthan A, Scarpini C, Tachtatzis P, Verma S, Penrhyn-Lowe S, Harvey R, et al. Hepatocyte senescence predicts progression in non-alcohol-related fatty liver disease. J Hepatol. 2013;58:549\u201356. https:\/\/doi.org\/10.1016\/j.jhep.2012.10.031","journal-title":"J Hepatol"},{"key":"4442_CR38","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1016\/j.ajpath.2014.02.014","volume":"184","author":"J Wan","year":"2014","unstructured":"Wan J, Benkdane M, Alons E, Lotersztajn S, Pavoine C. M2 kupffer cells promote hepatocyte senescence: an IL-6-dependent protective mechanism against alcoholic liver disease. Am J Pathol. 2014;184:1763\u201372. https:\/\/doi.org\/10.1016\/j.ajpath.2014.02.014","journal-title":"Am J Pathol"},{"key":"4442_CR39","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.jhep.2012.10.002","volume":"58","author":"J An","year":"2013","unstructured":"An J, Mehrhof F, Harms C, L\u00e4ttig-T\u00fcnnemann G, Lee SLL, Endres M, et al. ARC is a novel therapeutic approach against acetaminophen-induced hepatocellular necrosis. J Hepatol. 2013;58:297\u2013305. https:\/\/doi.org\/10.1016\/j.jhep.2012.10.002","journal-title":"J Hepatol"},{"key":"4442_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2015.126","volume":"6","author":"M Deutsch","year":"2015","unstructured":"Deutsch M, Graffeo CS, Rokosh R, Pansari M, Ochi A, Levie EM, et al. Divergent effects of RIP1 or RIP3 blockade in murine models of acute liver injury. Cell Death Dis. 2015;6:e1759 https:\/\/doi.org\/10.1038\/cddis.2015.126","journal-title":"Cell Death Dis"},{"key":"4442_CR41","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1002\/hep.27939","volume":"62","author":"L Dara","year":"2015","unstructured":"Dara L, Johnson H, Suda J, Win S, Gaarde W, Han D, et al. Receptor interacting protein kinase 1 mediates murine acetaminophen toxicity independent of the necrosome and not through necroptosis. Hepatology. 2015;62:1847\u201357. https:\/\/doi.org\/10.1002\/hep.27939","journal-title":"Hepatology"},{"key":"4442_CR42","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1038\/cdd.2012.90","volume":"19","author":"S Jouan-Lanhouet","year":"2012","unstructured":"Jouan-Lanhouet S, Arshad MI, Piquet-Pellorce C, Martin-Chouly C, Moigne-Muller GL, Van Herreweghe F, et al. TRAIL induces necroptosis involving RIPK1\/RIPK3-dependent PARP-1 activation. Cell Death Differ. 2012;19:2003\u201314. https:\/\/doi.org\/10.1038\/cdd.2012.90","journal-title":"Cell Death Differ"},{"key":"4442_CR43","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1007\/s00109-015-1270-6","volume":"93","author":"MI Arshad","year":"2015","unstructured":"Arshad MI, Piquet-Pellorce C, Filliol A, L\u2019Helgoualc\u2019h A, Lucas-Clerc C, Jouan-Lanhouet S, et al. The chemical inhibitors of cellular death, PJ34 and Necrostatin-1, down-regulate IL-33 expression in liver. J Mol Med. 2015;93:867\u201378. https:\/\/doi.org\/10.1007\/s00109-015-1270-6","journal-title":"J Mol Med"},{"key":"4442_CR44","doi-asserted-by":"publisher","first-page":"706156","DOI":"10.1155\/2013\/706156","volume":"2013","author":"Y Zhou","year":"2013","unstructured":"Zhou Y, Dai W, Lin C, Wang F, He L, Shen M, et al. Protective effects of necrostatin-1 against concanavalin A-induced acute hepatic injury in mice. Mediators Inflamm. 2013;2013:706156\u201315. https:\/\/doi.org\/10.1155\/2013\/706156","journal-title":"Mediators Inflamm"},{"key":"4442_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2016.410","volume":"7","author":"G Marsman","year":"2016","unstructured":"Marsman G, Zeerleder S, Luken BM. Extracellular histones, cell-free DNA, or nucleosomes: differences in immunostimulation. Cell Death Dis. 2016;7:e2518 https:\/\/doi.org\/10.1038\/cddis.2016.410","journal-title":"Cell Death Dis"},{"key":"4442_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2016.303","volume":"7","author":"Z Wen","year":"2016","unstructured":"Wen Z, Lei Z, Yao L, Jiang P, Gu T, Ren F, et al. Circulating histones are major mediators of systemic inflammation and cellular injury in patients with acute liver failure. Cell Death Dis. 2016;7:e2391 https:\/\/doi.org\/10.1038\/cddis.2016.303","journal-title":"Cell Death Dis"},{"key":"4442_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/s40560-016-0135-6","volume":"4","author":"AK Penttila","year":"2016","unstructured":"Penttila AK, Rouhiainen A, Kyl\u00e4np\u00e4\u00e4 L, Mustonen H, Puolakkainen P, Rauvala H, et al. Circulating nucleosomes as predictive markers of severe acute pancreatitis. J Intensive Care. 2016;4:14 https:\/\/doi.org\/10.1186\/s40560-016-0135-6","journal-title":"J Intensive Care"},{"key":"4442_CR48","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.ajpath.2015.11.025","volume":"186","author":"C Kawai","year":"2016","unstructured":"Kawai C, Kotani H, Miyao M, Ishida T, Jemail L, Abiru H, et al. Circulating extracellular histones are clinically relevant mediators of multiple organ injury. Am J Pathol. 2016;186:829\u201343. https:\/\/doi.org\/10.1016\/j.ajpath.2015.11.025","journal-title":"Am J Pathol"},{"key":"4442_CR49","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1038\/nm.2053","volume":"15","author":"J Xu","year":"2009","unstructured":"Xu J, Zhang X, Pelayo R, Monestier M, Ammollo CT, Semeraro F, et al. Extracellular histones are major mediators of death in sepsis. Nat Med. 2009;15:1318\u201321. https:\/\/doi.org\/10.1038\/nm.2053","journal-title":"Nat Med"},{"key":"4442_CR50","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1056\/NEJMra0809139","volume":"361","author":"P Gines","year":"2009","unstructured":"Gines P, Schrier RW. Renal failure in cirrhosis. N. Engl J Med. 2009;361:1279\u201390. https:\/\/doi.org\/10.1056\/NEJMra0809139","journal-title":"N. Engl J Med"},{"key":"4442_CR51","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/j.jhep.2011.11.024","volume":"56","author":"N Shah","year":"2012","unstructured":"Shah N, Dhar D, Mohammed FEZ, Habtesion A, Davies NA, Jover-Cobos M, et al. Prevention of acute kidney injury in a rodent model of cirrhosis following selective gut decontamination is associated with reduced renal TLR4 expression. J Hepatol. 2012;56:1047\u201353. https:\/\/doi.org\/10.1016\/j.jhep.2011.11.024","journal-title":"J Hepatol"},{"key":"4442_CR52","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1097\/SHK.0000000000000596","volume":"46","author":"MG Shashaty","year":"2016","unstructured":"Shashaty MG, Reilly JP, Sims CA, Holena DN, Qing D, Forker CM, et al. Plasma levels of Receptor Interacting Protein Kinase-3 (RIP3), an essential mediator of necroptosis, are associated with acute kidney injury in critically ill trauma patients. Shock. 2016;46:139\u201343. https:\/\/doi.org\/10.1097\/SHK.0000000000000596","journal-title":"Shock"},{"key":"4442_CR53","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1021\/jm061016o","volume":"50","author":"PG Jagtap","year":"2007","unstructured":"Jagtap PG, Degterev A, Choi S, Keys H, Yuan J, Cuny GD, et al. Structure-activity relationship study of tricyclic necroptosis inhibitors. J Med Chem. 2007;50:1886\u201395. https:\/\/doi.org\/10.1021\/jm061016o","journal-title":"J Med Chem"},{"key":"4442_CR54","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/nm1196","volume":"11","author":"AJ Muller","year":"2005","unstructured":"Muller AJ, DuHadaway JB, Donover PS, Sutanto-Ward E, Prendergast GC. Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy. Nat Med. 2005;11:312\u20139. https:\/\/doi.org\/10.1038\/nm1196","journal-title":"Nat Med"}],"updated-by":[{"DOI":"10.1038\/s41419-022-04874-x","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T00:00:00Z","timestamp":1651190400000}}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-021-04442-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-021-04442-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-021-04442-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T09:53:13Z","timestamp":1669974793000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-021-04442-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,17]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,1]]}},"alternative-id":["4442"],"URL":"https:\/\/doi.org\/10.1038\/s41419-021-04442-9","relation":{"correction":[{"id-type":"doi","id":"10.1038\/s41419-022-04874-x","asserted-by":"object"}]},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,17]]},"assertion":[{"value":"21 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2022","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41419-022-04874-x","URL":"https:\/\/doi.org\/10.1038\/s41419-022-04874-x","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Rajiv Jalan has research collaborations with Yaqrit and Takeda. Rajiv Jalan is the inventor of OPA, which has been patented by UCL and licensed to Mallinckrodt Pharma. He is also the founder of Yaqrit Ltd. (a spin out company from University College London), Cyberliver Ltd. and Hepyx Ltd. C.E. has on-going research collaboration with Merz Pharmaceutical and Novartis. The other authors do not have any CoI to declare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5"}}